SJP-1602

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameSJP-1602
Drug Alias NameSJP-1602
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFocal adhesion kinase inhibitors
TargetsFocal adhesion kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamjin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSamjin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A